PIHN News 0.0061 05/30/2014 05:21:11 Polaris Intl Hldgs (PIH

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Polaris Intl Hldgs (PIHN) 0.0061 $PIHN

Polaris International Holdings, Inc. to Release Energy Drink Shot
Marketwire - Wed May 28, 8:06AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce it has reached an agreement with a Dallas based manufacturer to produce a proprietary energy drink shot product as part of its hemp based nutraceutical supplement line. The energy drink shot will be the 3rd nutraceutical product of the Company to go along with its hemp protein powder and brain health supplements.

Polaris International Holdings, Inc., to Release Brain Health Supplement
Marketwire - Wed May 21, 10:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line. The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.

Polaris International Holdings, Inc., to Release Brain Health Supplement nt
eTeligis - Wed May 21, 10:30AM CDT
PLANO, TX, United States, via eTeligis Inc., 05/21/2014 - - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line.The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.

Polaris International Holdings, Inc. to Launch Nutraceutical Line of Products
Marketwire - Fri May 16, 8:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) will be launching a new hemp-based nutraceutical supplement line in the Fall of 2014. The Company's first product will be a new proprietary blend hemp protein powder. The initial flavors of the product will be chocolate, vanilla, and strawberry.

Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed on Kentucky Farm
Marketwire - Thu May 01, 7:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.

Cannabis Sector Appears To Stabilize With New Advancements - Company Enters JV for 70 Acre Hemp Farm
PR Newswire - Tue Apr 22, 8:02AM CDT
Marijuana companies acquire resources with expansion in sight: Polaris International Holdings, Inc. (OTC: PIHN), Tranzbyte Corporation (OTC: ERBB), Planda (OTC: PLPL), Nuvilex, Inc. (OTC: NVLX), Latteno Food Corp. (OTC: LATF) and MediSwipe, Inc. (OTC: MWIP)

Polaris International Holdings Enters Joint Venture for Kentucky Hemp Project
PR Newswire - Tue Apr 22, 7:00AM CDT
Polaris International Holdings, Inc. (OTC: PIHN) has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.

PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
Marketwire - Wed Apr 09, 6:20AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.

PIHN Announces Procannas' Cannabinoid Transdermal Product Development
Marketwire - Mon Apr 07, 6:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, has begun development of a unique and proprietary transdermal patch capable of delivering cannabinoids directly through the skin. This hallmark solution is intended to address a significant, unmet need for individuals requiring long-term, time released delivery. The Company believes, subject to testing and trials to be initiated by our participating physicians, that the patch may able to deliver cannabinoids for up to 48 hours. The Company further expects that this mechanism of delivery could revolutionize the way cannabinoids are introduced into the blood stream minimizing the negative effects on lungs and other organs commonly seen in other delivery methods. The Company expects to be ready to begin trials in 90 days.

PIHN Hires New Medical Director to Start International Clinical Trials
Marketwire - Tue Apr 01, 5:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce the Company has added Dr. Vasthi Alvarez Avila as Medical Director and to the Corporate Board of Directors. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.

Polaris International Holdings Signs Agreement With India Based Affiliates and Secures New Offices
Marketwire - Thu Mar 20, 7:46AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it has completed an important agreement with GBISS, Inc. and its India based affiliates to begin project management and manufacturing of the Company's exclusive Procannas(R) Cannatrol pharmaceutical grade core ingredients and sub-formulations.

PIHN Signs Exclusive Rights to ProCannas(R) Cannabinoid Line
Marketwire - Wed Mar 19, 6:15AM CDT
Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas(R) product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas(R) line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas(R) Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 2

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 2

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 2

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 4

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 4

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 2

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Amy Wilson Joins ITSA Board: A New Era for UBI?

Updated Category News Views 5

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Continue Reading
PostalAnnex Lands at Stanford with New Service Hub

Updated Category News Views 2

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Tomorrow's Innovators: Young Inventors Prize 2025

Updated Category News Views 280

Highlighting Young Innovators and Their Contributions The European Patent Office (EPO) has revealed the top 10 global innovators for the inaugural edition of the Young Inventors Prize 2025. This program celebrates innovators under 30 who are addressing significant global challenges through innovative science and technology. Known collectively as Tomorrow Shapers, these...

Continue Reading
Intellia's NTLA-2002 Declares Progress in Treating Hereditary Angioedema

Updated Category News Views 112

Positive Phase 2 Results for NTLA-2002 in Hereditary Angioedema Treatment Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering gene editing company, has recently unveiled encouraging results from its Phase 2 clinical trial of NTLA-2002. This investigational therapy, which employs CRISPR technology, shows significant promise in treating hereditary angioedema (HAE), a...

Continue Reading
Lawn in Order Honored as Top Rated Lawn Service Company

Updated Category News Views 95

Lawn in Order Receives Top Client Recognition Lawn in Order has been awarded the prestigious title of a Top Client Rated Lawn Service Company, reflecting its outstanding achievements in delivering exceptional lawn care services and ensuring client satisfaction. Expertise in Lawn Care and Landscaping This Atlanta-based company stands out as a leader in lawn care and...

Continue Reading
Alliance Pharma Disclosures: Key Trading Insights Unveiled

Updated Category News Views 266

Key Information on Alliance Pharma plc’s Trading Activity Recent disclosures from Alliance Pharma plc highlight crucial transactions conducted by exempt principal traders. This type of trading is often a key indicator for investors, shedding light on underlying market dynamics. The insights gained from such disclosures help to develop a clearer picture of trading...

Continue Reading
Understanding Market Sentiment: Core Scientific Inc Analysis

Updated Category News Views 198

Market Sentiment Towards Core Scientific Inc The current market sentiment regarding Core Scientific Inc (NYSE: CORZ) shows an upward trend in short interest. The percentage of shares sold short has significantly risen by 11.84%, indicating a growing concern among traders. Presently, there are approximately 62.39 million shares sold short, which represents around 20.49% of...

Continue Reading